Downregulation of HNF4A enables transcriptomic reprogramming during the hepatic acute-phase response

Commun Biol. 2024 May 16;7(1):589. doi: 10.1038/s42003-024-06288-1.

Abstract

The hepatic acute-phase response is characterized by a massive upregulation of serum proteins, such as haptoglobin and serum amyloid A, at the expense of liver homeostatic functions. Although the transcription factor hepatocyte nuclear factor 4 alpha (HNF4A) has a well-established role in safeguarding liver function and its cistrome spans around 50% of liver-specific genes, its role in the acute-phase response has received little attention so far. We demonstrate that HNF4A binds to and represses acute-phase genes under basal conditions. The reprogramming of hepatic transcription during inflammation necessitates loss of HNF4A function to allow expression of acute-phase genes while liver homeostatic genes are repressed. In a pre-clinical liver organoid model overexpression of HNF4A maintained liver functionality in spite of inflammation-induced cell damage. Conversely, HNF4A overexpression potently impaired the acute-phase response by retaining chromatin at regulatory regions of acute-phase genes inaccessible to transcription. Taken together, our data extend the understanding of dual HNF4A action as transcriptional activator and repressor, establishing HNF4A as gatekeeper for the hepatic acute-phase response.

MeSH terms

  • Acute-Phase Reaction* / genetics
  • Acute-Phase Reaction* / metabolism
  • Animals
  • Down-Regulation
  • Gene Expression Regulation
  • Hepatocyte Nuclear Factor 4* / genetics
  • Hepatocyte Nuclear Factor 4* / metabolism
  • Humans
  • Liver* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Transcriptome*

Substances

  • Hepatocyte Nuclear Factor 4
  • HNF4A protein, human
  • Hnf4a protein, mouse